Reset Map15 Results
1733 Creekside Dr Folsom, CA, 95630 3911 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
1743 Creekside Dr, Suite 200 Folsom, CA, 95630 3911 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
50 Mill St. Arlington, Mass, 02476 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
1743 Creekside Drive Folsom, CA, 95630 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
1230 Soldiers Field Dr Boston, MA, 02135 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
325 W Germantown Pike Norristown, PA, 19403 4207 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
1000 Sandhill Road Reno, NV, 89521 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
9707 Medical Center Drive, Suite 230 | Rockville, MD 20850 Rockville, MD, 20850 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
4520 Executive Drive San Diego, CA, 92121 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
1230 Soldiers Field Rd Boston, MA, 02135 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
2001 Junipero Serra Blvd Suite 620 Daly City, CA, 94010 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
7850 Brier Creek Pkwy, Suite 310 Raleigh, NC, 27617 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
7850 Brier Creek Pkwy, Suite 310 Raleigh, North Carolina, 27617 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
325 W Germantown Pike, Suite 200 East Norriton, Pennsylvania, 19403 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
325 W Germantown Pike, Suite 200 East Norriton, PA, 19403 United StatesAccelerating Cell and Gene Therapy Research with High Quality Human Starting Materials CGT Global provides ethically sourced human biological materials and cell sourcing solutions for research, translational development, and cell and gene therapy programs. We support biopharma, biotech, academic, and clinical research teams with access to high quality leukopaks, isolated immune cells, donor material, and custom collection services. Our team specializes in helping researchers source the right starting material for complex studies, including immuno oncology, cell therapy development, assay development, donor screening, process development, and preclinical research. Product Offering CGT Global offers a broad portfolio of human cellular starting materials and donor based solutions, including: Leukopaks Fresh and cryopreserved leukopaks collected from healthy donors and customized to study needs. Link: https://www.cgt.global/leukopaks Isolated Cells Isolated immune cell populations including PBMCs, T cells, NK cells, B cells, monocytes, and other cell types available for research applications. Link: https://www.cgt.global/isolated-cells PBMCs Fresh and cryopreserved PBMCs from qualified donors for assay development, immunology research, screening, and translational studies. Link: https://www.cgt.global/pbmcs Mobilized Leukopaks and CD34+ Cells Mobilized starting material and stem cell related products for advanced research and development programs. Link: https://www.cgt.global/mobilized-leukopaks Custom Donor Recruitment and Collections Custom donor recruitment, screening, and collection programs designed around specific donor demographics, biomarkers, disease states, HLA type, CMV status, genetic markers, or study criteria. Clinical Trial and CGT Support CGT Global supports cell and gene therapy programs with donor sourcing, collection coordination, starting material logistics, and clinical trial support through a growing healthcare network. Link: https://cgt.global/gmp-leukopaks-engineered-for-clinical-excellence/ Why Researchers Work With CGT Global Researchers choose CGT Global for reliable access to high quality donor material, flexible sourcing options, responsive scientific support, and the ability to support both standard and custom collection needs. Our capabilities include: Custom donor recruitment Fresh and cryopreserved leukopaks Isolated immune cell sourcing Healthy and disease state donor material Donor screening and genotyping Recallable donor programs Flexible collection scheduling Cold chain and logistics coordination Research and translational program support Cell and gene therapy starting material support Supporting Cell and Gene Therapy Development High quality starting material is critical to the success of cell and gene therapy development. CGT Global helps research teams reduce sourcing friction by providing access to qualified donors, customizable collection options, and scientific support throughout the procurement process. Whether your team needs a standard leukopak, a specific immune cell population, or a donor matching complex criteria, CGT Global can help identify and deliver material aligned with your study requirements. Resources Learn more about human starting material sourcing and cell therapy research: Everything CGT Global Offers: Starting Materials, Isolated Cells, and Clinical Grade Supply https://cgt.global/everything-cgt-global-offers-starting-materials-isolated-cells-and-clinical-grade-supply/ Fresh vs Cryopreserved Leukopaks for T Cell Expansion and CAR T Manufacturing https://cgt.global/fresh-vs-cryopreserved-leukopaks-for-car-t-manufacturing/ From Donor Recall to Data Integrity: The Operational Backbone of Ex Vivo Cell Therapy https://cgt.global/from-donor-recall-to-data-integrity-the-operational-backbone-of-ex-vivo-cell-therapy/ Bulk CD34+ Isolation from Mobilized Leukopaks: GCSF vs GCSF + PLX vs PLX https://cgt.global/bulk-cd34-isolation-from-mobilized-leukopaks-gcsf-vs-gcsf-plx-vs-plx/ Why CGT Global Is Positioned to Support the Next Wave of Cell and Gene Therapies https://cgt.global/cell-therapy-infrastructure-gmp-starting-material-clinical-trial-support-and-hospital-networks/ Fast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities https://cgt.global/fast-track-your-therapy-pipeline-with-cgt-globals-clinical-capabilities/ Choosing the Right Starting Material for Cell Therapy Development https://cgt.global/leukopak-vs-pbmc-vs-whole-blood-whats-the-difference-and-which-one-do-you-need/ Contact Us Email Orders@cgt.global For questions about product availability, donor criteria, custom collections, or study specific sourcing needs, contact CGT Global through Scientist.com or visit: https://www.cgt.global
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.